Contineum Therapeutics, Inc. · NASDAQ:CTNM

Perceptive Advisors LLC reported a 7.50% stake in Contineum Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Perceptive Advisors LLC reported a 7.50% stake in Contineum Therapeutics, Inc., 1,441,249 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
7.50%
Shares
1,441,249
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC7.50%1,441,249
Joseph Edelman7.50%1,441,249
Perceptive Life Sciences Master Fund, Ltd.7.50%1,441,249

Source

View original at SEC

Related